Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B (paradigm™7)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03075670
Recruitment Status : Completed
First Posted : March 9, 2017
Last Update Posted : November 22, 2019
Information provided by (Responsible Party):
Novo Nordisk A/S

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 8, 2017
Actual Study Completion Date : December 8, 2017